Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (171-180 of 290) with videos related to

Pageof 29
Sort By:
Antonie Van Leeuwenhoek|August 31, 2021
Characterization of clinical Ralstonia strains and their taxonomic positionAd C Fluit, Jumamurat R Bayjanov, María Díez Aguilar, et al.
Pediatric Pulmonology|January 24, 2007
The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosisDamian G Downey, S Lorraine Martin, Martin Dempster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradationSinéad Weldon, Paul McNally, Noel G McElvaney, et al.
The European Respiratory Journal|February 2, 2018
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosisKatherine O'Neill, Judy M Bradley, Alastair Reid, et al.
The Ulster Medical Journal|March 29, 2020
STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)Hongjie Wen, John McCaughan, Bettina C Schock, et al.
Pulmonary Pharmacology & Therapeutics|April 6, 2018
Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug-device combinationPamela J McShane, Jeffry G Weers, Thomas E Tarara, et al.
Respiratory Medicine|August 2, 2008
Respiratory viral infection in exacerbations of COPDTerence E McManus, Anne-Marie Marley, Noreen Baxter, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 15, 2013
Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cellsCatriona Kelly, Paul Canning, Paul J Buchanan, et al.
Plos One|November 3, 2020
Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 studyHarm A W M Tiddens, Eleni-Rosalina Andrinopoulou, Joe McIntosh, et al.
Contemporary Clinical Trials|May 13, 2017
The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasisTimothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, et al.
Pageof 29

Showing results (171-180 of 290) with videos related to

Sort By:
Pageof 29
Antonie Van Leeuwenhoek|August 31, 2021
Characterization of clinical Ralstonia strains and their taxonomic positionAd C Fluit, Jumamurat R Bayjanov, María Díez Aguilar, et al.
Pediatric Pulmonology|January 24, 2007
The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosisDamian G Downey, S Lorraine Martin, Martin Dempster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradationSinéad Weldon, Paul McNally, Noel G McElvaney, et al.
The European Respiratory Journal|February 2, 2018
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosisKatherine O'Neill, Judy M Bradley, Alastair Reid, et al.
The Ulster Medical Journal|March 29, 2020
STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)Hongjie Wen, John McCaughan, Bettina C Schock, et al.
Pulmonary Pharmacology & Therapeutics|April 6, 2018
Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug-device combinationPamela J McShane, Jeffry G Weers, Thomas E Tarara, et al.
Respiratory Medicine|August 2, 2008
Respiratory viral infection in exacerbations of COPDTerence E McManus, Anne-Marie Marley, Noreen Baxter, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 15, 2013
Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cellsCatriona Kelly, Paul Canning, Paul J Buchanan, et al.
Plos One|November 3, 2020
Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 studyHarm A W M Tiddens, Eleni-Rosalina Andrinopoulou, Joe McIntosh, et al.
Contemporary Clinical Trials|May 13, 2017
The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasisTimothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, et al.
Pageof 29